The use and abuse of commercial kits used to detect autoantibodies
about
Autoimmune liver serology: current diagnostic and clinical challengesAdvances and applications of multiplexed diagnostic technologies in autoimmune diseases.Autoantibodies in lupus nephritis patients requiring renal transplantation.Microbead-based technologies in diagnostic autoantibody detection.Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases: It is all about the patient!Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases.Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes.Need for an Ethical Framework for Testing for Systemic Diseases in Dental Clinics.Determination of Anti-nuclear Antibody Pattern Distribution and Clinical Relationship.Advances in understanding newer autoantibodies and their role as biomarkers in systemic lupus erythematosus.Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.The prevalence of antinuclear antibodies in patients with sarcoidosis.The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence.An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing.Guidelines for Antinuclear Antibody Testing.Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015
P2860
Q24644140-25FD6688-0E02-4817-B9DC-FF5DB2EEE6A1Q33253420-30B7659A-230C-4ECC-ABF8-EE9FF92CEE4EQ33292537-DB54B697-CE42-4CCE-B530-B6E20C0AEF23Q34621309-F02A17A6-5951-41EE-AE9D-9D892C66E152Q35309739-B2DBEF9E-7297-4F99-B85D-8F73779D1E5AQ36272782-DB98FCF0-3187-4961-8B8F-474C4A36AE7CQ37592015-B1F4D324-ACAF-4C4D-A4D6-2F2C26A03B92Q37613681-C54AEB62-04B0-4A7F-963D-28A89E5A1B7CQ37722033-3E215371-9807-4E8A-B264-F040BC4E25A9Q38089261-A1A22A7A-7A77-45A8-A626-6B4BABE9401BQ38883608-D1D84F1A-2E12-482D-835A-DCDF9203F0B7Q41594110-36347051-A60E-4437-A5FB-1369BBBFFFC7Q47759362-649E484B-6F10-4A43-9307-2A66533D19CBQ51280041-60035612-C641-4539-B10F-BBEDB53420A3Q55108110-47A4AF10-BA8E-47B8-9224-30F75B1B9FCCQ58985221-F4CA16C0-F69A-4C7B-B4C7-9E25489FA60E
P2860
The use and abuse of commercial kits used to detect autoantibodies
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The use and abuse of commercial kits used to detect autoantibodies
@ast
The use and abuse of commercial kits used to detect autoantibodies
@en
The use and abuse of commercial kits used to detect autoantibodies
@nl
type
label
The use and abuse of commercial kits used to detect autoantibodies
@ast
The use and abuse of commercial kits used to detect autoantibodies
@en
The use and abuse of commercial kits used to detect autoantibodies
@nl
prefLabel
The use and abuse of commercial kits used to detect autoantibodies
@ast
The use and abuse of commercial kits used to detect autoantibodies
@en
The use and abuse of commercial kits used to detect autoantibodies
@nl
P2093
P2860
P921
P356
P1476
The use and abuse of commercial kits used to detect autoantibodies
@en
P2093
Allan Wiik
Mark L Fritzler
Susan G Barr
P2860
P2888
P304
P356
10.1186/AR782
P407
P577
2003-06-09T00:00:00Z
P5875
P6179
1018834484